377780-72-8Relevant articles and documents
Mononuclear Copper(I) complexes based on phenanthroline derivatives P^N^N^P tetradentate ligands: Syntheses, crystal structure, photochemical properties
Chen, Hao,Xu, Liang-Xuan,Yan, Li-Juan,Liu, Xue-Fen,Xu, Dan-Dan,Yu, Xiao-Cong,Fan, Jin-Xuan,Wu, Qing-An,Luo, Shu-Ping
, (2019/11/26)
Two novel heteroleptic Cu(I) complexes with the single tetradentate ligands have been designed and synthesized from phenanthroline. The complexes having one copper structure were fully characterized by NMR, ESI-MS and the single-crystal X-ray structures. Their photoelectric chemical properties were investigated by using cyclic voltammetry, UV/vis and fluorescence spectroscopy. Compared with the classic Cu(P^P)(N^N) complexes, this distorted tetrahedral coordination structure of Cu(P^N^N^P) complexes showed a wider excitation wavelength and a red-shifted about 100 nm emission peak, due to the link function between phenanthroline and phosphorus ligands. Moreover, the copper complex B having the naphthyl link groups displayed high red-emissive photoluminescence quantum efficiency (PLQY), which was up to 3.8%.
PHARMACEUTICALLY ACTIVE PYRAZOLO-TRIAZINE AND/OR PYRAZOLO-PYRIMIDINE DERIVATIVES
-
Page/Page column 33; 50; 52, (2019/11/04)
The present invention relates to pyrazolo [1,5 -a] [1,3,5 ]triazine and pyrazolo[1,5-a] pyrimidine derivatives and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the prophylaxis and/or treatment of cell proliferative diseases, inflammatory diseases, immunological diseases, cardiovascular diseases and infectious diseases. Furthermore, the present invention is directed towards pharmaceutical compositions containing at least one of the pyrazo lo [1,5-a][1,3,5 ]triazine and pyrazolo [1,5-a]pyrimidine derivatives and/or pharmaceutically acceptable salts thereof.
Phenyl borate compound and benzoyl peroxide detection kit containing same
-
Paragraph 0058; 0063; 0064; 0065; 0066; 0067; 0068, (2017/12/27)
The invention relates to the technical field of benzoyl peroxide detection and in particular relates to a phenyl borate compound and a benzoyl peroxide detection kit containing the same. The benzoyl peroxide detection kit comprises a reagent stock solution a and a reagent stock solution b, wherein the reagent stock solution a is a phosphate buffer solution of ethanol, which has the pH (Potential of Hydrogen) value of 6 to 8; the reagent stock solution b is an organic solvent solution of the phenyl borate compound. The reagent stock solution b in the benzoyl peroxide detection kit provided by the invention has relatively weak fluorescence; after the reagent stock solution b reacts with benzoyl peroxide, the fluorescence intensity is remarkably enhanced and strong absorption is generated at a part with the wavelength of 690nm to 750nm; the fluorescence is remarkably enhanced at the part with the wavelength of 706nm; a fluorescence emission waveband is a near-infrared light region and has less background interference, so that the accuracy and the sensitivity are relatively high; a fluorescent probe has specificity on the benzoyl peroxide and is free from interference of other common inorganic salt ions and oxidization species.